Cure8 research brief
A new chemiluminescent probe may help researchers detect and visualize peroxynitrite, a reactive species linked to inflammation in ulcerative colitis, which could aid research into disease mechanisms and early detection methods.
Researchers in IBD biomarkers and imaging; clinician-researchers interested in ulcerative colitis diagnostics; imaging and probe developers.
This Analytical Chemistry abstract reports a new chemiluminescent probe (DCM-C) designed to detect peroxynitrite (ONOO–). The probe is based on an α,α-dicyanoolefin scaffold, has a short two-step synthesis, and showed high selectivity and a very large signal-to-background ratio in experimental tests and supporting DFT calculations.
The authors used the probe in living cell imaging (reported low cytotoxicity) and in a mouse model of ulcerative colitis to monitor ONOO– changes with high contrast. The paper frames this tool as potentially useful for early diagnosis and for studying inflammatory processes in UC.
This is a lab-based proof-of-concept (chemical probe development and preclinical imaging) rather than a clinical diagnostic or treatment study. It indicates potential future utility for research and possibly diagnostics but does not provide evidence about human clinical use or outcomes.
Structured-content depth: abstract — the summary and details are drawn from the article abstract. Findings are preclinical (cells and mouse model) and not equivalent to a validated clinical diagnostic.
Review the original publication for the complete reporting, methods, and context.
Funding disclosed by the source: Basic Research Program of Jiangsu Province, award BK20252073; Fundamental Research Funds for the Central Universities, award 2632026XCZX01; Fundamental Research Funds for the Central Universities, award 2632026ZD06
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
The probe targets azoreductase-driven hypoxia, a mechanism linked to ulcerative colitis and other hypoxia-associated diseases; a reliable real-time imaging method could help research and eventually guide treatments.
FAP appears linked to both inflammation and fibrosis in IBD; distinguishing cellular versus extracellular FAP might help develop or validate fibrosis biomarkers that detect fibrostenotic disease.
This study reports real-world data on mirikizumab in adults with ulcerative colitis, focusing on clinical and endoscopic remission and inflammatory markers — outcomes patients and clinicians use to judge treatment...
